Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

February 2025 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In February 2025, FDA received 107,692 drug adverse event reports. In February 2024, FDA received 115,592.

In February 2025, FDA received 210,014 medical device reports. In February 2024, FDA received 193,344.

By drug reports received, February 2025 was number 6 of the 12 months of 2025. FDA received 110,207 drug reports a month on average in the 12 months before February 2025.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to February 2025
0100,000200,000202320242025

Drugs in the reports

The table has the 133 drug pages with 250 or more reports in February 2025. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of February 2025 name as a suspect product, in order of name
DrugReports in the month
Acetaminophen1,033
Actemra407
Adalimumab643
Adapalene666
Aimovig277
Albuterol sulfate295
Alprazolam299
Amlodipine365
Aspirin324
Atorvastatin420
Benlysta341
Bevacizumab370
Botox289
Cabometyx4,475
Candesartan258
Capecitabine293
Caplyta297
Carbidopa levodopa557
Carboplatin842
Certolizumab pegol325
Cimzia398
Cisplatin388
Clozapine397
Clozaril253
Cosentyx805
Creon300
Cyclophosphamide937
Cyclosporine376
Dapagliflozin581
Definity476
Dexamethasone717
Diazepam251
Diclofenac287
Diclofenac sodium336
Docetaxel371
Doxorubicin331
Dupixent6,582
Eligard1,124
Eliquis682
Emgality348
Enbrel576
Erelzi276
Etoposide369
Ezetimibe291
Fentanyl366
Finasteride3,204
Fluorouracil422
Folic acid314
Furosemide314
Gabapentin640
Genotropin645
Human immunoglobulin g740
Humira1,250
Hydroxychloroquine259
Ibrance416
Ibuprofen422
Imbruvica316
Infliximab515
Isotretinoin265
Jakafi372
Keppra281
Kesimpta308
Kevzara323
Keytruda738
Lamotrigine272
Lantus Solostar418
Leflunomide285
Lenalidomide914
Levetiracetam535
Linezolid388
Lisdexamfetamine dimesylate290
Lorazepam251
Lumryz655
Lupkynis1,018
Metformin354
Methotrexate1,093
Methotrexate sodium327
Methylprednisolone385
Mirena288
Mounjaro1,968
Mycophenolate mofetil604
Nemluvio437
Nexium453
Nivolumab516
Nucala547
Nuplazid743
Ocrevus476
Olanzapine447
Omalizumab442
Opdivo513
Orencia692
Orgovyx550
Otezla278
Oxaliplatin504
Oxycodone303
Oxycodone hydrochloride311
Ozempic704
Paclitaxel568
Pantoprazole283
Pembrolizumab346
Pluvicto262
Pomalyst591
Prednisolone577
Prednisone1,253
Pregabalin267
Prolia287
Quetiapine349
Ramipril314
Remicade463
Remodulin258
Repatha613
Revlimid1,131
Rinvoq1,174
Rituximab1,249
Sertraline476
Simponi520
Skyrizi1,316
Spravato329
Stelara505
Sulfasalazine292
Tacrolimus688
Taltz272
Trelegy Ellipta339
Tremfya416
Trulicity367
Truvada291
Vedolizumab646
Venclexta289
Venetoclax280
Vincristine263
Xeljanz708
Xolair389
Zepbound1,467

Reaction terms in the reports

The table has the 120 reaction terms with 500 or more reports in February 2025. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of February 2025 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort901
Abdominal painstomach or belly pain1,049
Abdominal pain upperupper stomach pain1,049
Accidental exposure to product780
Acute kidney injurysudden loss of kidney function751
Adverse drug reactiona harmful or unpleasant reaction (the term names a medicine)2,305
Adverse eventan unwanted medical event, type not specified891
Alopeciahair loss855
Anaemialow red blood cells771
Anxietyanxiety1,118
Arthralgiajoint pain2,078
Astheniaweakness or lack of energy1,727
Asthmaasthma864
Back painback pain1,148
Blood glucose increasedraised blood sugar reading621
Blood pressure increaseda raised blood pressure reading1,036
Cerebrovascular accidentstroke581
Chest discomfortchest discomfort552
Chest painchest pain757
Chillschills or shivering533
Completed suicidedeath by suicide517
Condition aggravatedthe condition being treated got worse1,905
Confusional stateconfusion789
Constipationconstipation1,213
Coughcough1,651
Covid-19COVID-19 infection1,149
Deaththe patient died; cause not stated by this term4,065
Decreased appetitereduced appetite1,410
Dehydrationdehydration524
Depressionlow mood894
Dermatitis atopic858
Device issuea problem with the device579
Device leakagethe device leaked553
Diarrhoealoose or frequent stools3,653
Disease progressionthe disease advanced599
Dizzinesslight-headedness or unsteadiness2,190
Drug dose omission by device862
Drug hypersensitivityan allergic-type reaction (the term names a medicine)729
Drug ineffectivethe medicine did not work as expected6,095
Drug interactionan interaction between medicines625
Drug intolerancethe medicine was not tolerated625
Dry skindry skin946
Dyspnoeashortness of breath2,521
Eczemaeczema579
Erythemaskin redness1,095
Falla fall1,554
Fatiguetiredness4,105
Feeling abnormalfeeling odd or not right826
Gait disturbancedifficulty walking807
Gastrointestinal disorder670
General physical health deteriorationgeneral decline in health835
Headachehead pain2,745
Hospitalisationadmission to hospital1,051
Hot flusha hot flush510
Hypersensitivityan allergic-type reaction832
Hypertensionhigh blood pressure1,160
Hypoaesthesianumbness681
Hypotensionlow blood pressure824
Illness1,401
Inappropriate schedule of product administrationthe product was taken at the wrong times1,933
Incorrect dose administeredthe wrong dose was given2,033
Infectionan infection, type not specified814
Influenzaflu1,506
Injection site painpain where the injection was given1,904
Insomniadifficulty sleeping1,223
Intentional overdosea deliberate overdose507
Intentional product use issuedeliberate use not as intended730
Joint swellinga swollen joint666
Loss of consciousnesspassing out542
Malaisegeneral feeling of being unwell1,810
Malignant neoplasm progression780
Maternal exposure during pregnancythe mother took the medicine during pregnancy658
Memory impairmentmemory problems624
Migrainemigraine538
Muscle spasmsmuscle cramps875
Muscular weaknessmuscle weakness512
Myalgiamuscle pain770
Nasopharyngitisa cold1,295
Nauseafeeling sick3,713
Neuropathy peripheralnerve damage in hands or feet564
Neutropenialow neutrophils, a type of white blood cell692
No adverse eventno adverse event was reported1,156
Off label useused for a purpose or in a way not on the label8,166
Oropharyngeal painsore throat507
Overdosea dose above the recommended amount575
Painpain, site not specified2,430
Pain in extremitypain in an arm or leg1,230
Paraesthesiatingling or pins and needles597
Peripheral swellingswelling of the arms or legs895
Pneumonialung infection2,073
Product dose omission issuea dose was missed4,007
Product storage errorthe product was stored wrongly558
Product use in unapproved indicationused for a purpose not on the label1,981
Product use issuea problem in how the product was used1,226
Pruritusitching2,549
Pyrexiafever1,559
Rashskin rash2,496
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease659
Seizurea fit or convulsion693
Sinusitissinus infection567
Somnolencedrowsiness902
Stomatitissore mouth549
Suicidal ideationthoughts of suicide512
Swellingswelling510
Therapeutic product effect incomplete502
Therapy interrupted1,147
Thrombocytopenialow platelets612
Tinnitusringing in the ears512
Toxicity to various agentspoisoning or toxic effect of one or more substances761
Treatment failurethe treatment did not work572
Tremorshaking703
Urinary tract infectionbladder or urinary infection850
Urticariahives1,098
Vision blurredblurred vision565
Visual impairmentreduced vision689
Vomitingbeing sick2,404
Weight decreasedweight loss1,452
Weight increasedweight gain1,042
Wheezingwheezing516
Wrong technique in product usage processthe product was used in the wrong way969

Devices in the reports

The table has the 100 device pages with 250 or more reports in February 2025. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of February 2025 name, in order of name
Brand nameReports in the month
Alaris System2,655
Allura Xper FD545
Autosoft 90479
Autosoft Xc1,030
Azurion306
BioHorizons Inc.1,603
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim372
BLT ?3.3mm NC, SLA? 12mm, TiZr, Loxim307
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP361
BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP282
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim349
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim698
BLT ?4.1mm RC, SLA? 12mm, TiZr, Loxim280
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim395
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP540
BLT ?4.1mm RC, SLActive? 12mm, TiZr, NTP282
BLT ?4.1mm RC, SLActive? 8mm, TiZr, NTP366
BLT ?4.8mm RC, SLA? 10mm, TiZr, Loxim269
BLT ?4.8mm RC, SLA? 8mm, TiZr, Loxim259
BLT ?4.8mm RC, SLActive? 10mm, TiZr, NTP275
BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP298
Byte Night Aligners346
C1 coni con implant D3.75 L10mm, SP342
C1 coni con implant D4.20 L10mm, SP258
CADD-Solis VIP Ambulatory Infusion Pump284
CapSureFix Novus Lead MRI SureScan1,367
Dexcom G6 Continuous Glucose Monitoring System7,488
Dexcom G7 Continuous Glucose Monitoring System13,587
DreamStation Auto BiPAP982
DreamStation Auto CPAP7,320
DreamStation CPAP532
DreamStation CPAP Pro775
Dreamstation Go Auto292
Duoderm465
Dymic289
Emblem Mri S-Icd296
Endowrist2,511
FreeStyle Libre 2450
FreeStyle Libre 3492
Hd Camera Head278
HeartWare Ventricular Assist System - Pump353
Impella CP253
Ingevity+265
Inspira Smooth Silicone Gel Filled Breast Implant443
Inspira Textured Silicone Gel Filled Breast Implant261
Intellis510
Lance internal hex. implant dia. 3.75 L 11.50mm264
Libre 2 Sensor FreeStyle1,041
Libre 3 Sensor FreeStyle693
LifeVest WCD 4000 System925
McGRATH MAC354
MENTOR MemoryGel Breast Implant657
MiniMed 770G US System BLE Connect 3.0 mg/dL357
MiniMed 780G OUS System BLE Connect 3.0 mmol/L874
MiniMed 780G US System BLE Connect 3.0 mg/dL1,782
NobelActive Internal RP 4.3x10mm736
NobelActive Internal RP 4.3x11.5mm354
NobelActive Internal RP 4.3x13mm332
NobelActive Internal RP 4.3x8.5mm280
NobelActive Internal RP 5.0x10mm298
NobelActive TiUltra RP 4.3x10mm332
NobelParallel CC RP 4.3x10mm574
NobelParallel CC RP 4.3x11.5mm340
NobelParallel CC RP 4.3x8.5mm278
NobelParallel CC TiUltra RP 4.3x10mm286
NobelReplace CC PMC RP 4.3x10mm428
NobelReplace CC PMC RP 4.3x8mm272
NobelReplace CC RP 4.3x10mm422
Octrode Lead Kit, 60cm Length394
Omnipod 5 Automated Insulin Delivery System761
Omnipod 5 Pod953
Omnipod 5 Pods1,604
Omnipod DASH Insulin Management System495
Pentax523
Perclose ProStyle621
Proclaim 5 Elite Implantable Pulse Generator281
Pump 1886 780G OUS BLE Pump mg/dL1,290
PUMP MMT-1884L MM780G BLE 3.0 mg/ml711
Pyxis Medstation Es System2,353
Pyxis Medstation System468
REMstar Auto300
REMstar Auto A-Flex1,077
REMstar AutoA-Flex484
REMstar Pro C-Flex+787
SelectSecure MRI SureScan326
Sensor Mmt-7040a Guardian4 5pk Us315
Seven internal hex. implant dia. 3.75 L 10mm335
Smartphone Android App: Pump Connect528
Sprint Quattro Secure S MRI SureScan407
StealthStation S8 system390
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobile A454
t:slim X2 Insulin Pump with Control-IQ Technology823
t:slim X2 Insulin Pump with Interoperable Technology1,104
t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)11,548
Tandem Mobi Insulin Pump with Interoperable Technology2,399
Tec316
Tendril Sts446
Thoratec HeartMate 3 LVAS Implant Kit276
Transmitter Mmt-7841zn Gst5g Us947
Transmitter Mmt-7841zw Gst5g Ous491

Cite this page

Reported Reactions. February 2025: adverse event reports received by FDA. https://reportedreactions.com/month/2025-02/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for February 2025 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 107,692 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.